Awarded

El objeto del contrato viene determinado por el suministro del principio activo denominado "INEBILIZUMAB100MG/10ML SC", con el fin de atender las necesidades derivadas de la actividad habitual de este centro sanitario.

Track this recordFree account — get alerted when a contract here runs out.
Winners
AMGEN S.A.
Contract value
€83,250
Bids received
1
Published
11 Aug 2026
Awarded
5 Aug 2026
Contract start
5 Aug 2026
Contract end
6 Aug 2027estimated

More awards from this buyer